APA (7 ম সংস্করণ) উদ্ধৃতি

Shawn, I. H., & Jamiruddin, M. R. (2024). Assessing therapeutic safety and efficacy of Pazopanib, Pembrolizumab plus Axitinib and Nivolumab plus Ipilimumab in Renal Cell Carcinoma: A systematic review and meta-analysis. Brac University.

শিকাগো স্টাইল (17 তম সংস্করণ) উদ্ধৃতি

Shawn, Ibna Hasan, এবং Mohd. Raeed Jamiruddin. Assessing Therapeutic Safety and Efficacy of Pazopanib, Pembrolizumab Plus Axitinib and Nivolumab Plus Ipilimumab in Renal Cell Carcinoma: A Systematic Review and Meta-analysis. Brac University, 2024.

M.L.A (8 ম সংস্করণ) উদ্ধৃতি

Shawn, Ibna Hasan, এবং Mohd. Raeed Jamiruddin. Assessing Therapeutic Safety and Efficacy of Pazopanib, Pembrolizumab Plus Axitinib and Nivolumab Plus Ipilimumab in Renal Cell Carcinoma: A Systematic Review and Meta-analysis. Brac University, 2024.

সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.